Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Bridgebio Pharma Inc. (BBIO)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
Perceptive Advisors

Joseph Edelman

6,706,268 $143,983 3.87%
2. 2,617,566 $56,199 3.42%
3.
Viking Global

Andreas Halvorsen

26,620,991 $571,553 2.97%
4. 46,548 $999 -23% 0.52%
5.
SCGE Management

Christopher Lyle

415,978 $8,931 -30% 0.45%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$17.00 2,647,100 Large Shareholder 36,900,661 2019-07-01 Filing
$17.00 14,000 Officer 14,000 2019-07-01 Filing
$17.00 7,000 Officer 180,767 2019-07-01 Filing
$17.00 55,500 Officer 368,446 2019-07-01 Filing
$17.00 4,705,900 Large Shareholder 26,620,991 2019-06-27 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 3,835,722 $82,353 42.93%
2. 6,746,511 $144,847 0.58%
3. 23,500 $504 0.5%
4. 538,330 $11,558 0.1%
5. 13,000 $279 0.06%